Induction of innate immune responses by SIV in vivo and in vitro: Differential expression and function of RIG-I and MDA5

Journal of Infectious Diseases

Volumn 204, Issue 7, 2011, Pages 1104-1114

  Co, Juliene G ^a   Witwer, Kenneth W ^a   Gama, Lucio ^a   Zink, M Christine ^a   Clements, Janice E ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DOUBLE STRANDED RNA; MELANOMA DIFFERENTIATION ASSOCIATED PROTEIN 5; MESSENGER RNA; MYXOVIRUS RESISTANCE PROTEIN A; RETINOIC ACID INDUCIBLE PROTEIN I; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN; CONTROLLED STUDY; DISEASE SEVERITY; IN VITRO STUDY; IN VIVO STUDY; INNATE IMMUNITY; LENTIVIRUS INFECTION; MACACA; MACROPHAGE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RNA SYNTHESIS; SIMIAN IMMUNODEFICIENCY VIRUS; VIRUS IMMUNITY;

ANIMALS; BRAIN; ENCEPHALITIS, VIRAL; GTP-BINDING PROTEINS; IMMUNITY, INNATE; INTERFERON-ALPHA; INTERFERON-BETA; MACACA NEMESTRINA; MACROPHAGES; MODELS, ANIMAL; RNA HELICASES; RNA, MESSENGER; SEVERITY OF ILLNESS INDEX; SIMIAN IMMUNODEFICIENCY VIRUS; STATISTICS, NONPARAMETRIC; TIME FACTORS;

EID: 80052518621     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir469     Document Type: Article

References (45)

1. Resnick L., diMarzo-Veronese F., Schupbach J., et al. Intra-blood-brain-barrier synthesis of HTLV-III-specific IgG in patients with neurologic symptoms associated with AIDS or AIDS-related complex. N Engl J Med 1985; 313:1498-1504 (Pubitemid 16182478)
2. Chiodi F., Albert J., Olausson E., et al. Isolation frequency of human immunodeficiency virus from cerebrospinal fluid and blood of patients with varying severity of HIV infection. AIDS Res Hum Retroviruses 1988; 4:351-358
3. An S.F., Groves M., Gray F., Scaravilli F. Early entry and widespread cellular involvement of HIV-1 DNA in brains of HIV-1 positive asymptomatic individuals. J Neuropathol Exp Neurol 1999; 58:1156-1162 (Pubitemid 29519839)
4. Barber S.A., Gama L., Dudaronek J.M., Voelker T., Tarwater P.M., Clements J.E. Mechanism for the establishment of transcriptional HIV latency in the brain in a simian immunodeficiency virus-macaque model. J Infect Dis 2006; 193:963-970
5. Barber S.A., Herbst D.S., Bullock B.T., Gama L., Clements J.E. Innate immune responses and control of acute simian immunodeficiency virus replication in the central nervous system. J Neurovirol 2004; 10(Suppl 1):15-20. (Pubitemid 38325088)
6. Hartshorn K.L., Neumeyer D., Vogt M.W., Schooley R.T., Hirsch M.S. Activity of interferons alpha, beta, and gamma against human immunodeficiency virus replication in vitro. AIDS Res Hum Retroviruses 1987; 3:125-133 (Pubitemid 18079257)
7. Minagawa T., Mizuno K., Hirano S., et al. Detection of high levels of immunoreactive human beta-1 interferon in sera from HIV-infected patients. Life Sci 1989; 45:iii-vii. (Pubitemid 19251920)
8. Michaelis B., Levy J.A. HIV replication can be blocked by recombinant human interferon beta. AIDS 1989; 3:27-31. (Pubitemid 19058454)
9. Zink M.C., Clements J.E. A novel simian immunodeficiency virus model that provides insight into mechanisms of human immunodeficiency virus central nervous system disease. J Neurovirol 2002; 8(Suppl 2): 42-48 (Pubitemid 36097775)
10. Witwer K.W., Gama L., Li M., et al. Coordinated regulation of SIV replication and immune responses in the CNS. PLoS One 2009; 4:e8129.
11. Zink M.C., Coleman G.D., Mankowski J.L., et al. Increased macrophage chemoattractant protein-1 in cerebrospinal fluid precedes and predicts simian immunodeficiency virus encephalitis. J Infect Dis 2001; 184:1015-1021 (Pubitemid 32955118)
12. Zink M.C., Suryanarayana K., Mankowski J.L., et al. High viral load in the cerebrospinal fluid and brain correlates with severity of simian immunodeficiency virus encephalitis. J Virol 1999; 73:10480-10488
13. Barber S.A., Gama L., Li M., et al. Longitudinal analysis of simian immunodeficiency virus (SIV) replication in the lungs: Compartmentalized regulation of SIV. J Infect Dis 2006; 194:931-938 (Pubitemid 44454079)
14. Clements J.E., Babas T., Mankowski J.L., et al. The central nervous system as a reservoir for simian immunodeficiency virus (SIV): Steady-state levels of SIV DNA in brain from acute through asymptomatic infection. J Infect Dis 2002; 186:905-913
15. Honda Y., Rogers L., Nakata K., et al. Type I interferon induces inhibitory 16-kD CCAAT/ enhancer binding protein (C/EBP)beta, repressing the HIV-1 long terminal repeat in macrophages: Pulmonary tuberculosis alters C/EBP expression, enhancing HIV-1 replication. J Exp Med 1998; 188:1255-1265 (Pubitemid 28478014)
16. Kawai T., Akira S. Innate immune recognition of viral infection. Nat Immunol 2006; 7:131-137 (Pubitemid 43135878)
17. Yoneyama M., Kikuchi M., Natsukawa T., et al. The RNA helicase RIG-I has an essential function in double-stranded RNA-induced innate antiviral responses. Nat Immunol 2004; 5:730-737 (Pubitemid 39023305)
18. Hornung V., Ellegast J., Kim S., et al. 5&|prime;-Triphosphate RNA is the ligand for RIG-I. Science 2006; 314:994-997
19. Kato H., Takeuchi O., Mikamo-Satoh E., et al. Length-dependent recognition of double-stranded ribonucleic acids by retinoic acid-inducible gene-I and melanoma differentiation-associated gene 5. J Exp Med 2008; 205:1601-1610 (Pubitemid 351962024)
20. Kawai T., Takahashi K., Sato S., et al. IPS-1, an adaptor triggering RIG-I-and Mda5-mediated type I interferon induction. Nat Immunol 2005; 6:981-988 (Pubitemid 41486182)
21. Bowie A.G., Unterholzner L. Viral evasion and subversion of pattern-recognition receptor signalling. Nat Rev Immunol 2008; 8:911-922
22. Alammar L., Gama L., Clements J.E. Simian immunodeficiency virus infection in the brain and lung leads to differential type I IFN signaling during acute infection. J Immunol 2011; 186:4008-4018
23. Lukacs N. Detection of virus infection in plants and differentiation between coexisting viruses by monoclonal antibodies to double-stranded RNA. J Virol Methods 1994; 47:255-272 (Pubitemid 24185755)
24. Sioud M., Furset G., Cekaite L. Suppression of immunostimulatory siRNA-driven innate immune activation by 2′-modified RNAs. Biochem Biophys Res Commun 2007; 361:122-126 (Pubitemid 47102276)
25. Flaherty M.T., Hauer D.A., Mankowski J.L., Zink M.C., Clements J.E. Molecular and biological characterization of a neurovirulent molecular clone of simian immunodeficiency virus. J Virol 1997; 71:5790-5798 (Pubitemid 27304914)
26. Schefe J.H., Lehmann K.E., Buschmann I.R., Unger T., Funke-Kaiser H. Quantitative real-time RT-PCR data analysis: Current concepts and the novel "gene expression's CT difference" formula. J Mol Med 2006; 84:901-910 (Pubitemid 44655868)
27. Dudaronek J.M., Barber S.A., Clements J.E. CUGBP1 is required for IFNbeta-mediated induction of dominant-negative CEBPbeta and suppression of SIV replication in macrophages. J Immunol 2007; 179: 7262-7269
28. Weber F., Wagner V., Rasmussen S.B., Hartmann R., Paludan S.R. Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses. J Virol 2006; 80:5059-5064
29. Yoneyama M., Fujita T. Function of RIG-I-like receptors in antiviral innate immunity. J Biol Chem 2007; 282:15315-15318 (Pubitemid 47093255)
30. Wodrich H., Krausslich H.G. Nucleocytoplasmic RNA transport in retroviral replication. Results Probl Cell Differ 2001; 34:197-217.
31. Ooms M., Abbink T.E., Pham C., Berkhout B. Circularization of the HIV-1 RNA genome. Nucleic Acids Res 2007; 35:5253-5261 (Pubitemid 47394208)
32. Berkhout B. Structure and function of the human immunodeficiency virus leader RNA. Prog Nucleic Acid Res Mol Biol 1996; 54:1-34.
33. Baudin F., Marquet R., Isel C., Darlix J.L., Ehresmann B., Ehresmann C. Functional sites in the 5&|prime; region of human immunodeficiency virus type 1 RNA form defined structural domains. J Mol Biol 1993; 229:382-397 (Pubitemid 23080387)
34. Harrison G.P., Lever A.M. The human immunodeficiency virus type 1 packaging signal and major splice donor region have a conserved stable secondary structure. J Virol 1992; 66:4144-4153
35. Huthoff H., Berkhout B. 2 alternating structures of the HIV-1 leader RNA. RNA 2001; 7:143-157 (Pubitemid 32381937)
36. Watts J.M., Dang K.K., Gorelick R.J., et al. Architecture and secondary structure of an entire HIV-1 RNA genome. Nature 2009; 460:711-716
37. Overholser E.D., Coleman G.D., Bennett J.L., et al. Expression of simian immunodeficiency virus (SIV) nef in astrocytes during acute and terminal infection and requirement of nef for optimal replication of neurovirulent SIV in vitro. J Virol 2003; 77:6855-6866 (Pubitemid 36666879)
38. Judge A.D., Sood V., Shaw J.R., Fang D., McClintock K., MacLachlan I. Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nat Biotechnol 2005; 23:457-462 (Pubitemid 41724921)
39. Uzri D., Gehrke L. Nucleotide sequences and modifications that determine RIG-I/RNA binding and signaling activities. J Virol 2009; 83:4174-4184
40. Chang J.J., Altfeld M. Innate immune activation in primary HIV-1 infection. J Infect Dis 2010; 202(Suppl 2):S297-S301
41. Chiu Y.H., Macmillan J.B., Chen Z.J. RNA polymerase III detects cytosolic DNA and induces type I interferons through the RIG-I pathway. Cell 2009; 138:576-591
42. Choi M.K., Wang Z., Ban T., et al. A selective contribution of the RIG-I-like receptor pathway to type I interferon responses activated by cytosolic DNA. Proc Natl Acad Sci U S A 2009; 106:17870-17875
43. Kumagai Y., Kumar H., Koyama S., Kawai T., Takeuchi O., Akira S. Cutting Edge: TLR-Dependent viral recognition along with type I IFN positive feedback signaling masks the requirement of viral replication for IFN-{alpha} production in plasmacytoid dendritic cells. J Immunol 2009; 182:3960-3964
44. Fredericksen B.L., Wei B.L., Yao J., Luo T., Garcia J.V. Inhibition of endosomal/ lysosomal degradation increases the infectivity of human immunodeficiency virus. J Virol 2002; 76:11440-11446 (Pubitemid 35231300)
45. Schaeffer E., Soros V.B., Greene W.C. Compensatory link between fusion and endocytosis of human immunodeficiency virus type 1 in human CD4 T lymphocytes. J Virol 2004; 78:1375-1383 (Pubitemid 38095847)